|
WO2013017631A1
|
|
Kisspeptide-pentasaccharide conjugates
|
|
WO2012084711A1
|
|
N-substituted azetidine derivatives
|
|
EP2548877A1
|
|
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
WO2011157443A1
|
|
(11β,17α)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY- 19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
|
|
EP2487159A1
|
|
RorgammaT inhibitors
|
|
MX2012009208A
|
|
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds.
|
|
EP2496569A2
|
|
Heterocyclic derivatives
|
|
CA2766291A1
|
|
Injectable formulations containing asenapine and method of treatment using same
|
|
US2010331292A1
|
|
Substituted 16,17-annellated steroid compounds for use in womens healthcare
|
|
AU2010210776A1
|
|
Isoxazole-3-carboxamide derivatives
|
|
AU2010211114A1
|
|
Isoxazole-5-carboxamide derivatives
|
|
AU2009226966A1
|
|
Preparation of a pharmaceutical composition for increasing bone mineral density
|
|
TW200821294A
|
|
An orally active thrombin inhibitor
|
|
AU2006301240A1
|
|
Antithrombotic compound
|
|
CN101312747A
|
|
Anticoagulant antithrombotic dual inhibitors comprising a biotin label
|
|
TW200745105A
|
|
Non-steroidal glucocorticoid receptor modulators
|
|
TW200640923A
|
|
Non steroidal glucocorticoid receptor modulators
|
|
TW200638947A
|
|
Conjugates of a polypeptide and an oligosaccharide
|
|
EP1841418A2
|
|
Glycine reuptake inhibitors for treating drug and alcohol dependence
|
